Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.46B |
| 2 |
NVIDIA
NVDA
|
+$1.08B |
| 3 |
State Street Health Care Select Sector SPDR ETF
XLV
|
+$609M |
| 4 |
Moderna
MRNA
|
+$599M |
| 5 |
UBS Group
UBS
|
+$478M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.11B |
| 2 |
Apple
AAPL
|
+$679M |
| 3 |
Palo Alto Networks
PANW
|
+$450M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$428M |
| 5 |
Microsoft
MSFT
|
+$361M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 14.97% |
| 2 | Financials | 8.75% |
| 3 | Healthcare | 7.15% |
| 4 | Consumer Discretionary | 6.46% |
| 5 | Communication Services | 5.81% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2501
ICU Medical
ICUI
$4.21B
| $1.62M | ﹤0.01% |
6,830
-141,099
| -95% | -$33M |
|
|
MODN
2502
DELISTED
MODEL N, INC.
MODN
| $1.62M | ﹤0.01% |
53,863
+24,620
| +84% | +$770K |
|
2503
Cerus
CERS
$433M
| $1.62M | ﹤0.01% |
237,319
+128,577
| +118% | +$866K |
|
2504
Shenandoah Telecom
SHEN
$664M
| $1.61M | ﹤0.01% |
63,266
+24,021
| +61% | +$674K |
|
|
RETA
2505
DELISTED
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
| $1.61M | ﹤0.01% |
60,891
+35,192
| +137% | +$2.72M |
|
2506
Safety Insurance
SAFT
$1.52B
| $1.6M | ﹤0.01% |
18,881
+5,247
| +38% | +$421K |
|
2507
US Physical Therapy
USPH
$1.2B
| $1.6M | ﹤0.01% |
16,703
+5,017
| +43% | +$503K |
|
2508
iShares US Medical Devices ETF
IHI
$3.13B
| $1.59M | ﹤0.01% |
24,220
| – | – |
|
2509
Quanterix
QTRX
$164M
| $1.59M | ﹤0.01% |
37,557
+21,913
| +140% | +$1.02M |
|
|
UNVR
2510
DELISTED
Univar Solutions Inc.
UNVR
| $1.59M | ﹤0.01% |
56,040
-39,570
| -41% | -$1.07M |
|
2511
Woodward
WWD
$21.3B
| $1.58M | ﹤0.01% |
14,442
-22,626
| -61% | -$2.54M |
|
|
COUP
2512
CALL
DELISTED
Coupa Software Incorporated
COUP
| $1.58M | ﹤0.01% |
10,000
-5,800
| -37% | -$1.19M |
|
2513
Apogee Enterprises
APOG
$826M
| $1.58M | ﹤0.01% |
32,772
+6,882
| +27% | +$301K |
|
|
CONN
2514
DELISTED
Conn's Inc.
CONN
| $1.58M | ﹤0.01% |
67,025
+23,052
| +52% | +$520K |
|
2515
Alpha and Omega Semiconductor
AOSL
$950M
| $1.57M | ﹤0.01% |
25,907
+3,338
| +15% | +$145K |
|
2516
Coeur Mining
CDE
$15.4B
| $1.57M | ﹤0.01% |
310,749
-107,609
| -26% | -$647K |
|
2517
CTS Corp
CTS
$1.83B
| $1.57M | ﹤0.01% |
42,654
-3,027
| -7% | -$106K |
|
|
SHOE
2518
Shoe Station Group
SHOE
$413M
| $1.57M | ﹤0.01% |
40,064
+12,207
| +44% | +$459K |
|
2519
Columbus McKinnon
CMCO
$553M
| $1.56M | ﹤0.01% |
33,791
+9,077
| +37% | +$438K |
|
2520
Chemed
CHE
$7.07B
| $1.56M | ﹤0.01% |
2,948
-5,413
| -65% | -$2.6M |
|
2521
MGP Ingredients
MGPI
$379M
| $1.56M | ﹤0.01% |
18,357
+7,681
| +72% | +$579K |
|
|
KAMN
2522
DELISTED
Kaman Corp
KAMN
| $1.56M | ﹤0.01% |
36,111
-1,047
| -3% | -$41.2K |
|
|
KREF
2523
KKR Real Estate Finance Trust
KREF
$448M
| $1.55M | ﹤0.01% |
74,572
+18,029
| +32% | +$388K |
|
2524
Peoples Bancorp
PEBO
$1.5B
| $1.55M | ﹤0.01% |
48,833
+28,729
| +143% | +$923K |
|
|
CGC
2525
PUT
Canopy Growth
CGC
$387M
| $1.55M | ﹤0.01% |
17,780
| – | – |
|
Similar funds
Barclays's Q4 2021 Portfolio in Review
As of Q4 2021, Barclays held 5,008 positions worth $268B, up 21% from $222B the previous quarter. Its ten largest holdings account for 30% of the portfolio.
Barclays deployed $30.5B of net new capital in Q4 2021, opening 209 new positions and adding to 2,223 existing holdings. Its largest new stake was UBS Group: 27,173,428 shares worth $486M.
By sector, the portfolio is most concentrated in Technology at 15% of assets, up from 14% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $1.11B trimmed.
- Barclays's largest Q4 2021 buy was UBS Group: 27,173,428 shares worth $486M.
- Barclays added most to iShares 20+ Year Treasury Bond ETF in Q4 2021, an estimated $1.46B increase.
- Barclays's biggest Q4 2021 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $1.11B.
- Barclays fully exited Vanguard Total International Bond ETF in Q4 2021, selling an estimated $89.8M.
- Barclays's ten largest holdings make up 30% of its $268B portfolio in Q4 2021.
- Barclays opened 209 new positions and closed 867 in Q4 2021.
- Barclays's portfolio value rose 21% quarter-over-quarter to $268B.
Based on Barclays's 13F filing for Q4 2021, filed 14 Feb 2022.